SLC7A11 and neoplasm: Further in vivo experiments revealed that SLC7A11 knockdown indeed suppressed the tumor-initiating ability (Fig. 6A, C), stem cell frequency of GC cells (Fig. 6B, D), and metastatic capacity (Fig. 6E).